Related references
Note: Only part of the references are listed.Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience
Anna Malczewska et al.
NEUROENDOCRINOLOGY (2021)
Neuroendocrine Tumor Omic Gene Cluster Analysis Amplifies the Prognostic Accuracy of the NETest
Mark Kidd et al.
NEUROENDOCRINOLOGY (2021)
A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood
K. Oberg et al.
ANNALS OF ONCOLOGY (2020)
Neuroendocrine neoplasia goes molecular - time for a change
Guido Rindi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy
Lisa Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors
Anna Malczewska et al.
NEUROENDOCRINOLOGY (2018)
The Genesis of the Neuroendocrine Tumors Concept: From Oberndorfer to 2018
Kjell Oberg
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)
The NETest The Clinical Utility of Multigene Blood Analysis - in the Diagnosis and Management of Neuroendocrine Tumors
Irvin M. Modlin et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
L. Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms
Mark Kidd et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood
Irvin M. Modlin et al.
PLOS ONE (2013)
Serum Pancreastatin The Long Sought Universal, Sensitive, Specific Tumor Marker for Neuroendocrine Tumors?
Tetsuhide Ito et al.
PANCREAS (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Metagenes Associated with Survival in Non-Small Cell Lung Cancer
Egon Urgard et al.
CANCER INFORMATICS (2011)
Serum peptide profiles in patients with carcinoid tumors
K Calhoun et al.
AMERICAN JOURNAL OF SURGERY (2003)
Monitoring minimal residual disease in AML: the right time for real time
U Jaeger et al.
ANNALS OF HEMATOLOGY (2003)
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative
PM Bossuyt et al.
ANNALS OF INTERNAL MEDICINE (2003)
Share Paper
